Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A protein particle vaccine containing multiple malaria epitopes

S C Gilbert1, M Plebanski, S J Harris

  • 1Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, UK.

Nature Biotechnology
|November 14, 1997
PubMed
Summary

Recombinant Ty virus-like particles (VLPs) carrying Plasmodium cytotoxic T lymphocyte (CTL) epitopes can induce protective immune responses in mice after one dose. Epitope processing from these VLPs was effective and unaffected by surrounding sequences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

The Journal of infection·2024
Same author

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

The Journal of infection·2024
Same author

The power of effective study design in animal experimentation: Exploring the statistical and ethical implications of asking multiple questions of a data set.

Brain, behavior, and immunity·2023
Same author

Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO).

Trials·2023
Same author

Malaria vaccines in the eradication era: current status and future perspectives.

Expert review of vaccines·2019
Same author

A flowcytometric analysis to efficiently quantify multiple innate immune cells and T Cell subsets in human blood.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2017

Area of Science:

  • Biotechnology
  • Immunology
  • Vaccine Development

Background:

  • Ty virus-like particles (VLPs) are single-protein structures producible in yeast.
  • Cytotoxic T lymphocyte (CTL) epitopes are crucial for adaptive immunity against pathogens like Plasmodium.
  • Developing effective vaccine platforms for eliciting strong CTL responses is a key challenge.

Purpose of the Study:

  • To evaluate the potential of recombinant Ty-VLPs as a vaccine platform.
  • To assess the ability of Ty-VLPs carrying multiple Plasmodium CTL epitopes to induce immune responses.
  • To investigate the processing and presentation of CTL epitopes from a concatenated string within Ty-VLPs.

Main Methods:

  • Production of recombinant Ty-VLPs in yeast.
  • Conjugation of up to 15 Plasmodium-derived CTL epitopes into a single string on Ty-VLPs.

Related Experiment Videos

  • Administration of Ty-VLPs to mice (single dose, without adjuvant).
  • In vitro and in vivo assessment of epitope processing and CTL response induction.

    • Main Results:

    • Recombinant Ty-VLPs carrying concatenated CTL epitopes were successfully produced.
    • A single administration of Ty-VLPs in mice elicited protective CTL responses.
    • Epitope processing from the string was efficient both in vitro and in vivo.
    • Flanking sequences did not impede the effective processing of individual epitopes.

    Conclusions:

    • Ty-VLPs represent a promising platform for developing subunit vaccines.
    • Single-dose Ty-VLP vaccines carrying multiple CTL epitopes can induce robust and protective immune responses.
    • The design of epitope strings for Ty-VLP vaccines allows for effective processing and presentation, independent of flanking sequences.